With reports that as many as 40 percent of Americans may have some difficulty swallowing tablets, the FDA released multiple guidances for sponsors of generic drugs on Monday, including a final guidance on how the physical attributes of generics may affect patients’ compliance with their drug regimens.
Source: Drug Industry Daily